I-Flow gets go-ahead for exports:
This article was originally published in Clinica
Following receipt of ISO 9001 certification and CE marking approval, I-Flow plans to begin exports of its ambulatory infusion systems to Europe immediately. The Californian company produces the SideKick, Paragon and VIVUS systems for administration of medical and nutritional therapies (see Clinica No 650/51, p 18).
You may also be interested in...
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Among the largest gaps in safety data is non-clinical research on CBD use's effect on developing fetus and adolescent brain, in utero/lactational exposure, reproductive toxicity and the potential for a latency period before toxicity, says FDA neuroscientist Andrew Shen.
The templates from the US agency provide guidance to manufacturers developing antibody tests for clinical or at-home use.